Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

Christian Karagiannidis, Carina Mostert, Corinna Hentschker, Thomas Voshaar, Jürgen Malzahn, Gerhard Schillinger, Jürgen Klauber, Uwe Janssens, Gernot Marx, Steffen Weber-Carstens, Stefan Kluge, Michael Pfeifer, Linus Grabenhenrich, Tobias Welte, Reinhard Busse, Christian Karagiannidis, Carina Mostert, Corinna Hentschker, Thomas Voshaar, Jürgen Malzahn, Gerhard Schillinger, Jürgen Klauber, Uwe Janssens, Gernot Marx, Steffen Weber-Carstens, Stefan Kluge, Michael Pfeifer, Linus Grabenhenrich, Tobias Welte, Reinhard Busse

Abstract

Background Nationwide, unbiased, and unselected data of hospitalised patients with COVID-19 are scarce. Our aim was to provide a detailed account of case characteristics, resource use, and outcomes of hospitalised patients with COVID-19 in Germany, where the health-care system has not been overwhelmed by the pandemic.

Methods: In this observational study, adult patients with a confirmed COVID-19 diagnosis, who were admitted to hospital in Germany between Feb 26 and April 19, 2020, and for whom a complete hospital course was available (ie, the patient was discharged or died in hospital) were included in the study cohort. Claims data from the German Local Health Care Funds were analysed. The data set included detailed information on patient characteristics, duration of hospital stay, type and duration of ventilation, and survival status. Patients with adjacent completed hospital stays were grouped into one case. Patients were grouped according to whether or not they had received any form of mechanical ventilation. To account for comorbidities, we used the Charlson comorbidity index.

Findings: Of 10 021 hospitalised patients being treated in 920 different hospitals, 1727 (17%) received mechanical ventilation (of whom 422 [24%] were aged 18-59 years, 382 [22%] were aged 60-69 years, 535 [31%] were aged 70-79 years, and 388 [23%] were aged ≥80 years). The median age was 72 years (IQR 57-82). Men and women were equally represented in the non-ventilated group, whereas twice as many men than women were in the ventilated group. The likelihood of being ventilated was 12% for women (580 of 4822) and 22% for men (1147 of 5199). The most common comorbidities were hypertension (5575 [56%] of 10 021), diabetes (2791 [28%]), cardiac arrhythmia (2699 [27%]), renal failure (2287 [23%]), heart failure (1963 [20%]), and chronic pulmonary disease (1358 [14%]). Dialysis was required in 599 (6%) of all patients and in 469 (27%) of 1727 ventilated patients. The Charlson comorbidity index was 0 for 3237 (39%) of 8294 patients without ventilation, but only 374 (22%) of 1727 ventilated patients. The mean duration of ventilation was 13·5 days (SD 12·1). In-hospital mortality was 22% overall (2229 of 10 021), with wide variation between patients without ventilation (1323 [16%] of 8294) and with ventilation (906 [53%] of 1727; 65 [45%] of 145 for non-invasive ventilation only, 70 [50%] of 141 for non-invasive ventilation failure, and 696 [53%] of 1318 for invasive mechanical ventilation). In-hospital mortality in ventilated patients requiring dialysis was 73% (342 of 469). In-hospital mortality for patients with ventilation by age ranged from 28% (117 of 422) in patients aged 18-59 years to 72% (280 of 388) in patients aged 80 years or older.

Interpretation: In the German health-care system, in which hospital capacities have not been overwhelmed by the COVID-19 pandemic, mortality has been high for patients receiving mechanical ventilation, particularly for patients aged 80 years or older and those requiring dialysis, and has been considerably lower for patients younger than 60 years.

Funding: None.

Copyright © 2020 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
Age distribution (A) and Charlson comorbidity index (B) Only adult patients aged 18 years or older were included in the analysis.
Figure 2
Figure 2
Duration of mechanical ventilation by ventilation type (A) Duration of mechanical ventilation by type of ventilation and survival status. Box plots show medians and IQRs. Means are shown with large circles. Outliers are shown with small circles. (B) Distribution of the duration of mechanical ventilation.
Figure 3
Figure 3
In-hospital mortality (A) In-hospital survival with and without mechanical ventilation. (B) In-hospital mortality with and without mechanical ventilation by age.
Figure 4
Figure 4
Duration of hospital stay and mechanical ventilation by survival status in ventilated patients Distribution of length of hospital stay (A) and duration of mechanical ventilation (B) in survivors and non-survivors.

References

    1. Robert Koch Institut Coronavirus disease 2019 (COVID-19) daily situation report of the Robert Koch Institute. July 15, 2020.
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242.
    1. Guan WJ, Ni ZY, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
    1. Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open. 2020;3
    1. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Nationale Intensive Care Evaluatie COVID-19 infecties op de verpleegafdeling. 2020.
    1. Sante Publique France Point épidémiologique hebdomadaire du 21 mai 2020. May 21, 2020.
    1. Centro Nacional de Epidemiología Situación de COVID-19 en España. 2020.
    1. Sciensano COVID-19—wekelijks epidemiologisch bulletin van 22 mei 2020. May 22, 2020.
    1. Wadhera RK, Wadhera P, Gaba P. Variation in COVID-19 hospitalizations and deaths across New York City boroughs. JAMA. 2020;323:2192–2195.
    1. Grasselli G, Zangrillo A, Zanella A. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323:1574–1581.
    1. Wu C, Chen X, Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–943.
    1. Cao B, Wang Y, Wen D. A trial of lopinavir-ritonavir in adults hospitalised with severe COVID-19. N Engl J Med. 2020;382:1787–1799.
    1. Richardson S, Hirsch JS, Narasimhan M. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052–2059.
    1. Docherty AB, Harrison EM, Green CA. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369
    1. Wunsch H. Mechanical ventilation in COVID-19: interpreting the current epidemiology. Am J Respir Crit Care Med. 2020;202:1–4.
    1. German Federal Ministry of Health Gesetzliche Krankenversicherung: Mitglieder, mitversicherte Angehörige und Krankenstand: Monatswerte Januar–April 2020. 2020.
    1. Busse R, Blümel M, Knieps F, Bärnighausen T. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet. 2017;390:882–897.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
    1. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.
    1. Ranieri VM, Rubenfeld GD, Thompson BT. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–2533.
    1. Intensive Care National Audit & Research Centre ICNARC report on COVID-19 in critical care. May 22, 2020.
    1. Puelles VG, Lütgehetmann M, Lindenmeyer MT. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020 doi: 10.1056/NEJMc2011400. published online May 13.
    1. COVIDSurg Collaborative Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396:27–38.
    1. Banerjee A, Pasea L, Harris S. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet. 2020;395:1715–1725.
    1. Chandra D, Stamm JA, Taylor B. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med. 2012;185:152–159.
    1. National Institute for Health and Care Excellence Acute kidney injury: prevention, detection and management. Dec 18, 2019.
    1. EuroELSO EuroELSO survey on ECMO use in adult COVID-19 patients in Europe. 2020.
    1. Salje H, Tran Kiem C, Lefrancq N. Estimating the burden of SARS-CoV-2 in France. Science. 2020 doi: 10.1126/science.abc3517. published online May 13.
Uncited References
    1. Organisation for Economic Co-operation and Development Beyond containment: health systems responses to COVID-19 in the OECD. 2020.

Source: PubMed

3
Prenumerera